Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage study
多靶点TKI联合纳武利尤单抗治疗免疫检查点抑制剂难治性晚期非小细胞肺癌患者的安全性和有效性:一项前瞻性、单臂、两阶段研究
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-12479-0
Zhang, Bo; Liu, Hongyu; Shi, Chunlei; Gao, Zhiqiang; Zhong, Runbo; Gu, Aiqin; Chu, Tianqing; Wang, Huimin; Xiong, Liwen; Zhang, Wei; Zhang, Xueyan; Yan, Bo; Teng, Jiajun; Wang, Weimin; Bai, Hao; Qiao, Rong; Cheng, Lei; Kuang, Yanbin; Zhao, Ruiying; Zhong, Hua; Han, Baohui